Literature DB >> 20182268

Too much of a good thing? Physician practices and patient willingness for less frequent pap test screening intervals.

Helen I Meissner1, Jasmin A Tiro, K Robin Yabroff, David A Haggstrom, Steven S Coughlin.   

Abstract

BACKGROUND: Recent guidelines recommend longer Pap test intervals. However, physicians and patients may not be adopting these recommendations.
OBJECTIVES: Identify (1) physician and practice characteristics associated with recommending a less frequent interval, and (2) characteristics associated with women's willingness to adhere to a 3-year interval. RESEARCH
DESIGN: We used 2 national surveys: (1) a 2006/2007 National Survey of Primary Care Physicians for physician cervical cancer screening practices (N = 1114), and (2) the 2005 Health Information Trends Survey for women's acceptance of longer Pap intervals (N = 2206). MEASURES AND METHODS: Physician recommendation regarding Pap intervals was measured using a clinical vignette involving a 35-year-old with no new sexual partners and 3 consecutive negative Pap tests; associations with independent variables were evaluated with logistic regression. In parallel models, we evaluated women's willingness to follow a 3-year Pap test interval.
RESULTS: A minority of physicians (32%) have adopted-but more than half of women are willing to adopt-3-year Pap test intervals. In adjusted models, physician factors associated with less frequent screening were: serving a higher proportion of Medicaid patients, white, non-Hispanic race, fewer years since medical school graduation, and US Preventive Services Task Force being very influential in physician clinical practice. Women were more willing to follow a 3-year interval if they were older, but less willing if they had personal or family experiences with cancer or followed an annual Pap test schedule.
CONCLUSIONS: Many women are accepting of a 3-year interval for Pap tests, although most primary care physicians continue to recommend shorter intervals.

Entities:  

Mesh:

Year:  2010        PMID: 20182268     DOI: 10.1097/MLR.0b013e3181ca4015

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  24 in total

1.  Use of electronic health record data to evaluate overuse of cervical cancer screening.

Authors:  Jason S Mathias; Dana Gossett; David W Baker
Journal:  J Am Med Inform Assoc       Date:  2012-01-19       Impact factor: 4.497

2.  Screening: HPV testing for cervical cancer: the good, the bad, and the ugly.

Authors:  Philip E Castle
Journal:  Nat Rev Clin Oncol       Date:  2010-07       Impact factor: 66.675

3.  Adherence to conservative management recommendations for abnormal pap test results in adolescents.

Authors:  Rebecca B Perkins; Jennifer R Jorgensen; Molly E McCoy; Sharon M Bak; Tracy A Battaglia; Karen M Freund
Journal:  Obstet Gynecol       Date:  2012-06       Impact factor: 7.661

4.  Patient knowledge and beliefs as barriers to extending cervical cancer screening intervals in Federally Qualified Health Centers.

Authors:  Nikki A Hawkins; Vicki B Benard; April Greek; Katherine B Roland; Diane Manninen; Mona Saraiya
Journal:  Prev Med       Date:  2013-09-05       Impact factor: 4.018

5.  Roles of Health Care Providers and Patients in Initiation of Unnecessary Papanicolaou Testing After Total Hysterectomy.

Authors:  Fangjian Guo; Yong-Fang Kuo
Journal:  Am J Public Health       Date:  2016-09-15       Impact factor: 9.308

6.  Papanicolaou tests: does lubricant reduce the quality or adequacy?

Authors:  G Michael Allan; Christina Korownyk; Noah Ivers
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

7.  Recommendations on screening for cervical cancer.

Authors:  James Dickinson; Eva Tsakonas; Sarah Conner Gorber; Gabriela Lewin; Elizabeth Shaw; Harminder Singh; Michel Joffres; Richard Birtwhistle; Marcello Tonelli; Verna Mai; Meg McLachlin
Journal:  CMAJ       Date:  2013-01-07       Impact factor: 8.262

8.  Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years.

Authors:  Michelle I Silver; Anne F Rositch; Darcy F Phelan-Emrick; Patti E Gravitt
Journal:  Cancer Causes Control       Date:  2017-11-09       Impact factor: 2.506

9.  Cervical Cancer Screening Intervals Preferred by U.S. Women.

Authors:  Crystale Purvis Cooper; Mona Saraiya
Journal:  Am J Prev Med       Date:  2018-07-20       Impact factor: 5.043

10.  Adherence to the 2012 national cervical cancer screening guidelines: a pilot study.

Authors:  Deanna G K Teoh; Amity E Marriott; Rachel Isaksson Vogel; Ryan T Marriott; Charles W Lais; Levi S Downs; Shalini L Kulasingam
Journal:  Am J Obstet Gynecol       Date:  2014-06-30       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.